I've been watching and doing my DD here for a while, but have never thought of the synergies with EMV, whom I have quite a large postition in (relative to my means). What an interesting thought. EMV is well worth a look imo, sorry to cross-promote, but it is perhaps worth noting:
Geoff Pocock: Non-executive director (EMV), Non-executive director (AGN). Emma Waldon: Company Secretary (EMV), Chief Financial Officer & Company Secretary (AGN) Professor Geoffrey Donnan: Clinical Advisory Board (EMV), Clinical Advisory Committee (AGN)
You'd think each company would be well aware of any potential synergies if they do indeed exist.
Looking to open a position here too, and thinking I better not leave it too much longer.
Anyway, good luck all. Cheers.
AGN Price at posting:
55.5¢ Sentiment: Buy Disclosure: Not Held
(20min delay)